How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Dragonfly Initiates Phase 2 Study of HER2 Targeting TriNKET™ DF1001

calendar_today December 6, 2022 person maura169 domain dragonfly-therapeutics

In Phase 1 DF1001 was well-tolerated and showed encouraging pharmacodynamic effects and clinical response, with tumor burden reductions…

open_in_new Read original post